Typical osteogenesis imperfecta, which is an autosomal dominant disorder connected with osteoporosis and bone frailty, is triggered by alteration in the genes for type I collagen. It has long been suspected that a recessive form of the disorder occurs. In view of the fact that loss of cartilage-associated protein or CRTAP, which is necessary for post-translational prolyl 3-hydroxylation of collagen initiates acute osteoporosis in mice, the researchers explored whether CRTAP deficiency is connected with recessive osteogenesis imperfecta. Three out of ten children with fatal or acute osteogenesis imperfecta, who have no primary collagen deficiency were discovered to have excess post-translational modification of collagen, were uncovered to possess a recessive condition resulting in CRTAP deficiency, signifying that prolyl 3-hydroxylation of type I collagen is vital for bone development.
Osteogenesis imperfecta also known as the brittle bone disease is an autosomal dominant genetic syndrome typified by bone frailty with vulnerability to fracture. The scientific extent of osteogenesis imperfecta ranging from type I to type IV develops from mild symptoms to a perinatal fatal condition. Transformations or mutations in type I collagen, which is the main structural protein of skin and bone, is the origin of majority of cases of osteogenesis imperfecta.
Type I collagen is called as heterotrimer. The main structure permits the procollagen chains to develop a triple helix with the chains lining up at their carboxyl ends and folding in the direction of the amino termini. Heterozygous mutations that have an effect to the main collagen structure produce average and serious osteogenesis imperfecta while reduced collagen generation triggers mild osteogenesis imperfecta. A recessive form of osteogenesis imperfecta has been suspected for a long time in several cases wherein impervious parents have at least one child with serious bone dysplasia. Propositions of supplementary dominant and recessive types of osteogenesis imperfecta from type V to type VII are established on histologic attributes of bone. These nonfatal forms do not include main primary collagen imperfections.
The researchers have identified ten children that had fatal or serious osteogenesis imperfecta with the absence of primary collagen mutations though with excess post-translational modification of type I collagen, which indicate deferred folding of the collagen helix. Most patients with osteogenesis imperfecta and have been modified excessively with collagen have a compositional mutation in one of the two chains of type I collagen. Nonetheless, in ten to fifteen percent of cases of osteogenesis imperfecta there was no finding of collagen mutation that leads to idea that alterations or mutations are present in other genes.
Both recessive and dominant fatal osteogenesis imperfecta may possibly result in elevated alteration of the type I collagen helix. Classic dominantly succeeded to osteogenesis imperfecta includes abnormalities in the primary sequence of the collagen chains that slow down triple helix development at the location of the abnormality that leads to the exposure of the component chains to the enhanced collagen modification by lysyl and prolyl hydroxylases at multiple locations  alongside the extent of the helix and hence initiated the slowing down of electrophoretic migration of collagen chains.